News

News
JNJ Press releases

Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection

Read full story
JNJ Press releases

What’s Brewing at JLINX?

Read full story
Partner news

BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders

Read full story
JNJ Press releases

JLINX Science Meets Business Symposium

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces New Collaboration with TMC

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces New Collaboration with Texas Medical Center to Spur Development of Breakthrough Medical Device Technologies

Read full story
JNJ Press releases

Johnson & Johnson, Texas Medical Center join forces to develop medical devices in Houston

Read full story
JNJ Press releases

J&J to create new Texas center to develop ‘breakthrough’ med tech

Read full story
Partner news

Padlock Therapeutics Appoints Adelene Perkins to Board of Directors

Read full story
Partner news

J&J's Ethicon Partners with Fogarty Institute to Back Next-Gen Device Innovation

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Collaborations with Canadian Biotechs Novera Therapeutics, Inc. and enGene, Inc.

Read full story
Partner news

enGene Announces Strategic Collaboration with Johnson & Johnson Innovation

Read full story
Partner news

Navitor Pharmaceuticals’ Scientific Founder Makes Landmark Discovery

Read full story
Partner news

NovoCure Prices IPO at $22 a Share

Read full story
Partner news

Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation

Read full story